[Automatic translation follows] Research Institute & Development for the Energy Transition & Ecological City. Created in 2014, Efficacity is the French R&D Institute dedicated to the energy and ecological transition of cities, founded under the aegis of the Future Investment Program (PIA) supported by the French Government. Efficacity is a unique partnership R&D center in France bringing together around thirty public and private actors. The institute brings together 100 researchers and experts from all backgrounds, working together to develop and implement innovative solutions to build the city of tomorrow: an energy efficient and massively decarbonized city. Efficacity is located in …

High quality statistics and data on Europe. Lawful good. EUROSTAT is the statistical office of the European Union. Our mission is to provide high quality statistics and data on Europe. Our values: Show respect for our staff, partners and users Strive for excellence in everything we do Drive innovation in official statistics Promote service orientation Uphold professional independence ESS partnership Eurostat produces European statistics in partnership with National Statistical Institutes and other national authorities in the EU Member States. This partnership is known as the European Statistical System (ESS). It also includes the statistical authorities of the European Economic Area …

Sectors: European Union

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare

Tags: CAC40 Sectors: Pharmaceutical

The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"​). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and …

Sectors: Research

We are dedicated to therapeutic progress to serve patient needs. Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and …

Sectors: Pharmaceutical

Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves …

Sectors: Public business cluster

[Automatic translation follows] 14 varied and complementary establishments are the Paris-Saclay University: 3 universities *, 4 grandes écoles ** and 7 research organizations ***. In total, we represent 48,000 students, 9,000 researchers and teacher-researchers, 4,600 doctoral students and 275 laboratories. 14 Various goal complementary institutions Make up University Paris-Saclay: 3 universities *, 4 Prestigious University-Level Colleges ** and 7 Research Organizations ***. WE represent 9,000 profits and researchers, 4,600 PhD Students, 275 Laboratories and 48,000 students. * University Paris-Sud, University Versailles St-Quentin-en-Yvelines and University of Evry. ** Graduate School Optical Institute, Agroparistech, CentralsUpelec, Normal School Paris-Saclay. *** CEA, CNRS, IHES, …

Sectors: Research